[Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes]

Related Experiment Video

Updated: Aug 30, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Antonia Sambola1, Valentín Fuster, Juan José Badimon

  • 1Servicio de Cardiología, Hospital de Terrassa, Barcelona, España. asambola@yahoo.com

Revista Espanola De Cardiologia
|October 18, 2003
PubMed

Insights

Systemic risk factors contribute to endothelial dysfunction, leading to atherosclerotic disease and acute coronary syndromes (ACS). Targeting tissue factor (TF) offers a new therapeutic strategy for ACS by reducing blood thrombogenicity.

Area of Science:

  • Cardiovascular Science
  • Pathophysiology
  • Molecular Biology

Context:

  • Endothelial dysfunction is a key mechanism in atherosclerotic disease and acute coronary syndromes (ACS).
  • Systemic risk factors like diabetes, hypercholesterolemia, and smoking promote a pro-thrombotic state.
  • Superficial plaque erosion contributes to ACS in a significant proportion of patients.

Purpose:

  • To explore the link between systemic risk factors, endothelial dysfunction, and thrombotic complications in ACS.
  • To investigate the role of tissue factor (TF) in heightened thrombogenicity associated with risk factors.
  • To identify potential therapeutic targets for ACS based on TF inhibition.

Summary:

  • Systemic risk factors impair endothelial function, promoting atherosclerotic plaque instability and thrombotic complications in ACS.
  • These risk factors increase blood thrombogenicity, partly through elevated circulating tissue factor (TF) levels, which activate the coagulation cascade.
  • This heightened thrombogenicity, driven by TF, exacerbates thrombus formation, triggering ACS events.

Impact:

  • Highlights the importance of aggressive management of cardiovascular risk factors.
  • Suggests that inhibiting tissue factor (TF) expression could be a novel therapeutic strategy for treating ACS.
  • Opens new research avenues for developing targeted therapies to prevent or treat ACS.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...